No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 4kv5A, 1.0000, 0.00, 1.000, 112, 112, SCFV GC1009 IN COMPLEX WITH TGF-BETA1.
2, 4kv5C, 0.9949, 0.28, 1.000, 112, 112, SCFV GC1009 IN COMPLEX WITH TGF-BETA1.
3, 4kv5B, 0.9923, 0.34, 1.000, 112, 112, SCFV GC1009 IN COMPLEX WITH TGF-BETA1.
4, 4kv5D, 0.9903, 0.39, 1.000, 112, 112, SCFV GC1009 IN COMPLEX WITH TGF-BETA1.
5, 3kfdB, 0.9707, 0.70, 1.000, 112, 112, TERNARY COMPLEX OF TGF-B1 REVEALS ISOFORM-SPECIFIC LIGAND RECOGNITION AND RECEPTOR RECRUITMENT IN THE SUPERFAMILY
6, 3kfdD, 0.9704, 0.71, 1.000, 112, 112, TERNARY COMPLEX OF TGF-B1 REVEALS ISOFORM-SPECIFIC LIGAND RECOGNITION AND RECEPTOR RECRUITMENT IN THE SUPERFAMILY
7, 3eo1I, 0.9626, 0.82, 0.768, 112, 112, STRUCTURE OF THE FAB FRAGMENT OF GC-1008 IN COMPLEX WITH TRANSFORMING GROWTH FACTOR-BETA 3
8, 3eo1C, 0.9626, 0.82, 0.768, 112, 112, STRUCTURE OF THE FAB FRAGMENT OF GC-1008 IN COMPLEX WITH TRANSFORMING GROWTH FACTOR-BETA 3
9, 3kfdC, 0.9606, 0.81, 1.000, 112, 112, TERNARY COMPLEX OF TGF-B1 REVEALS ISOFORM-SPECIFIC LIGAND RECOGNITION AND RECEPTOR RECRUITMENT IN THE SUPERFAMILY
10, 3kfdA, 0.9606, 0.81, 1.000, 112, 112, TERNARY COMPLEX OF TGF-B1 REVEALS ISOFORM-SPECIFIC LIGAND RECOGNITION AND RECEPTOR RECRUITMENT IN THE SUPERFAMILY
11, 2pjyA, 0.9600, 0.84, 0.768, 112, 112, STRUCTURAL BASIS FOR COOPERATIVE ASSEMBLY OF THE TGF-BETA SIGNALING COMPLEX
12, 3eo1L, 0.9595, 0.89, 0.768, 112, 112, STRUCTURE OF THE FAB FRAGMENT OF GC-1008 IN COMPLEX WITH TRANSFORMING GROWTH FACTOR-BETA 3
13, 3eo1F, 0.9595, 0.89, 0.768, 112, 112, STRUCTURE OF THE FAB FRAGMENT OF GC-1008 IN COMPLEX WITH TRANSFORMING GROWTH FACTOR-BETA 3
14, 4kxzE, 0.9576, 0.89, 0.714, 112, 112, CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008.
15, 4kxzA, 0.9549, 0.92, 0.714, 112, 112, CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008.
16, 4kxzD, 0.9526, 0.94, 0.714, 112, 112, CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008.
17, 1tgkA, 0.9520, 0.93, 0.768, 112, 112, HUMAN TRANSFORMING GROWTH FACTOR BETA 3 CRYSTALLIZED FROM PEG 4000
18, 1tgjA, 0.9513, 0.95, 0.768, 112, 112, HUMAN TRANSFORMING GROWTH FACTOR-BETA 3 CRYSTALLIZED FROM DIOXANE
19, 4kxzB, 0.9479, 1.00, 0.714, 112, 112, CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008.
20, 1tfgA, 0.8743, 1.66, 0.714, 112, 112, AN UNUSUAL FEATURE REVEALED BY THE CRYSTAL STRUCTURE AT 2.2 ANGSTROMS RESOLUTION OF HUMAN TRANSFORMING GROWTH FACTOR-BETA2
21, 2tgiA, 0.8724, 1.69, 0.714, 112, 112, CRYSTAL STRUCTURE OF TRANSFORMING GROWTH FACTOR-BETA2: AN UNUSUAL FOLD FOR THE SUPERFAMILY
22, 1klcB, 0.8615, 1.60, 0.991, 112, 111, SOLUTION STRUCTURE OF TGF-B1 NMR MINIMIZED AVERAGE STRUCTURE
23, 1klcA, 0.8615, 1.60, 0.991, 112, 111, SOLUTION STRUCTURE OF TGF-B1 NMR MINIMIZED AVERAGE STRUCTURE
24, 1klaA, 0.8608, 1.64, 0.991, 112, 111, SOLUTION STRUCTURE OF TGF-B1 NMR MODELS 1-17 OF 33 STRUCTURES
25, 1klaB, 0.8607, 1.64, 0.991, 112, 111, SOLUTION STRUCTURE OF TGF-B1 NMR MODELS 1-17 OF 33 STRUCTURES
26, 1kldB, 0.8103, 2.05, 0.973, 112, 111, SOLUTION STRUCTURE OF TGF-B1 NMR MODELS 18-33 OF 33 STRUCTURES
27, 1kldA, 0.8103, 2.05, 0.973, 112, 111, SOLUTION STRUCTURE OF TGF-B1 NMR MODELS 18-33 OF 33 STRUCTURES
28, 5tx2A, 0.7798, 1.10, 0.674, 92, 92, MINIATURE TGF-BETA2 3-MUTANT MONOMER
29, 5tx4B, 0.7776, 1.08, 0.761, 92, 92, DERIVATIVE OF MOUSE TGF-BETA2 WITH A DELETION OF RESIDUES 52-71 AND K25R R26K L51R A74K C77S L89V I92V K94R T95K I98V SINGLE AMINO ACID SUBSTITUTIONS BOUND TO HUMAN TGF-BETA TYPE II RECEPTOR ECTODOMAIN RESIDUES 15-130
30, 2qcwB, 0.7740, 1.68, 0.347, 104, 98, CRYSTAL STRUCTURE OF BONE MORPHOGENETIC PROTEIN-6 (BMP-6)
31, 5tx6B, 0.7736, 1.15, 0.761, 92, 92, STRUCTURE OF TGF-BETA2 DERIVATIVE WITH DELETION OF RESIDUES 52-71 AND 10 SINGLE AMINO ACID MUTATIONS (MMTGF-BETA2-7M)
32, 5tx2B, 0.7733, 1.18, 0.685, 92, 92, MINIATURE TGF-BETA2 3-MUTANT MONOMER
33, 2r53A, 0.7726, 2.02, 0.350, 107, 100, CRYSTAL STRUCTURE ANALYSIS OF BONE MORPHOGENETIC PROTEIN-6 VARIANT B2 (B2-BMP-6)
34, 4ui2B, 0.7725, 1.89, 0.343, 104, 99, CRYSTAL STRUCTURE OF THE TERNARY RGMB-BMP2-NEO1 COMPLEX
35, 2r52A, 0.7718, 1.82, 0.354, 105, 99, CRYSTAL STRUCTURE ANALYSIS OF BONE MORPHOGENETIC PROTEIN-6 (BMP-6)
36, 4uhzA, 0.7694, 1.91, 0.343, 104, 99, CRYSTAL STRUCTURE OF THE HUMAN RGMB-BMP2 COMPLEX CRYSTAL FORM 1
37, 2h62B, 0.7689, 1.72, 0.347, 103, 98, CRYSTAL STRUCTURE OF A TERNARY LIGAND-RECEPTOR COMPLEX OF BMP-2
38, 3qb4C, 0.7670, 2.16, 0.300, 106, 100, CRYSTAL STRUCTURE OF A TGF-BETA LIGAND-RECEPTOR COMPLEX
39, 4faoH, 0.7666, 1.91, 0.303, 105, 99, SPECIFICITY AND STRUCTURE OF A HIGH AFFINITY ACTIVIN-LIKE 1 (ALK1) SIGNALING COMPLEX
40, 4faoh, 0.7662, 1.92, 0.303, 105, 99, SPECIFICITY AND STRUCTURE OF A HIGH AFFINITY ACTIVIN-LIKE 1 (ALK1) SIGNALING COMPLEX
41, 4faog, 0.7661, 1.93, 0.303, 105, 99, SPECIFICITY AND STRUCTURE OF A HIGH AFFINITY ACTIVIN-LIKE 1 (ALK1) SIGNALING COMPLEX
42, 4faoG, 0.7657, 1.93, 0.303, 105, 99, SPECIFICITY AND STRUCTURE OF A HIGH AFFINITY ACTIVIN-LIKE 1 (ALK1) SIGNALING COMPLEX
43, 4faoS, 0.7656, 1.92, 0.303, 105, 99, SPECIFICITY AND STRUCTURE OF A HIGH AFFINITY ACTIVIN-LIKE 1 (ALK1) SIGNALING COMPLEX
44, 4faoa, 0.7654, 1.93, 0.303, 105, 99, SPECIFICITY AND STRUCTURE OF A HIGH AFFINITY ACTIVIN-LIKE 1 (ALK1) SIGNALING COMPLEX
45, 4faoT, 0.7650, 1.94, 0.303, 105, 99, SPECIFICITY AND STRUCTURE OF A HIGH AFFINITY ACTIVIN-LIKE 1 (ALK1) SIGNALING COMPLEX
46, 4faob, 0.7650, 1.93, 0.303, 105, 99, SPECIFICITY AND STRUCTURE OF A HIGH AFFINITY ACTIVIN-LIKE 1 (ALK1) SIGNALING COMPLEX
47, 4faoM, 0.7648, 1.93, 0.303, 105, 99, SPECIFICITY AND STRUCTURE OF A HIGH AFFINITY ACTIVIN-LIKE 1 (ALK1) SIGNALING COMPLEX
48, 4faoA, 0.7644, 1.92, 0.303, 105, 99, SPECIFICITY AND STRUCTURE OF A HIGH AFFINITY ACTIVIN-LIKE 1 (ALK1) SIGNALING COMPLEX
49, 4faoB, 0.7643, 1.94, 0.303, 105, 99, SPECIFICITY AND STRUCTURE OF A HIGH AFFINITY ACTIVIN-LIKE 1 (ALK1) SIGNALING COMPLEX
50, 4ui0B, 0.7624, 1.98, 0.343, 104, 99, CRYSTAL STRUCTURE OF THE HUMAN RGMB-BMP2 COMPLEX CRYSTAL FORM 2
51, 2bhkA, 0.7617, 2.10, 0.283, 105, 99, CRYSTAL STRUCTURE OF HUMAN GROWTH AND DIFFERENTIATION FACTOR 5 (GDF5)
52, 5tx6A, 0.7607, 0.72, 0.784, 88, 88, STRUCTURE OF TGF-BETA2 DERIVATIVE WITH DELETION OF RESIDUES 52-71 AND 10 SINGLE AMINO ACID MUTATIONS (MMTGF-BETA2-7M)
53, 1waqA, 0.7607, 1.92, 0.286, 104, 98, CRYSTAL STRUCTURE OF HUMAN GROWTH AND DIFFERENTIATION FACTOR 5 (GDF-5)
54, 4uhyB, 0.7605, 2.01, 0.343, 105, 99, CRYSTAL STRUCTURE OF THE HUMAN RGMA-BMP2 COMPLEX
55, 4n1dA, 0.7571, 2.19, 0.310, 105, 100, NODAL/BMP2 CHIMERA NB250
56, 4ui1A, 0.7568, 2.09, 0.343, 104, 99, CRYSTAL STRUCTURE OF THE HUMAN RGMC-BMP2 COMPLEX
57, 4faoN, 0.7565, 1.94, 0.306, 104, 98, SPECIFICITY AND STRUCTURE OF A HIGH AFFINITY ACTIVIN-LIKE 1 (ALK1) SIGNALING COMPLEX
58, 4ui0A, 0.7562, 2.05, 0.343, 101, 99, CRYSTAL STRUCTURE OF THE HUMAN RGMB-BMP2 COMPLEX CRYSTAL FORM 2
59, 4uhyA, 0.7549, 2.05, 0.343, 104, 99, CRYSTAL STRUCTURE OF THE HUMAN RGMA-BMP2 COMPLEX
60, 4ui1B, 0.7536, 2.13, 0.343, 105, 99, CRYSTAL STRUCTURE OF THE HUMAN RGMC-BMP2 COMPLEX
61, 2qcqA, 0.7534, 2.35, 0.293, 107, 99, CRYSTAL STRUCTURE OF BONE MORPHOGENETIC PROTEIN-3 (BMP-3)
62, 5hk5B, 0.7522, 2.16, 0.303, 105, 99, STRUCTURE OF THE GREM2-GDF5 INHIBITORY COMPLEX
63, 2qcqB, 0.7521, 2.18, 0.296, 108, 98, CRYSTAL STRUCTURE OF BONE MORPHOGENETIC PROTEIN-3 (BMP-3)
64, 5hk5A, 0.7516, 2.17, 0.303, 105, 99, STRUCTURE OF THE GREM2-GDF5 INHIBITORY COMPLEX
65, 2h64A, 0.7514, 2.36, 0.340, 105, 100, CRYSTAL STRUCTURE OF A TERNARY LIGAND-RECEPTOR COMPLEX OF BMP-2
66, 1bmpA, 0.7512, 2.05, 0.337, 104, 98, BONE MORPHOGENETIC PROTEIN-7
67, 5hk5C, 0.7497, 2.19, 0.303, 105, 99, STRUCTURE OF THE GREM2-GDF5 INHIBITORY COMPLEX
68, 5hk5D, 0.7495, 2.19, 0.303, 105, 99, STRUCTURE OF THE GREM2-GDF5 INHIBITORY COMPLEX
69, 3evsB, 0.7473, 1.99, 0.299, 104, 97, CRYSTAL STRUCTURE OF THE GDF-5:BMP RECEPTOR IB COMPLEX.
70, 1lxiA, 0.7450, 2.15, 0.337, 104, 98, REFINEMENT OF BMP7 CRYSTAL STRUCTURE
71, 1reuA, 0.7437, 2.26, 0.347, 103, 98, STRUCTURE OF THE BONE MORPHOGENETIC PROTEIN 2 MUTANT L51P
72, 3qb4A, 0.7421, 2.28, 0.303, 105, 99, CRYSTAL STRUCTURE OF A TGF-BETA LIGAND-RECEPTOR COMPLEX
73, 1lx5A, 0.7379, 2.22, 0.327, 104, 98, CRYSTAL STRUCTURE OF THE BMP7/ACTRII EXTRACELLULAR DOMAIN COMPLEX
74, 3hh2A, 0.7377, 2.81, 0.317, 109, 101, CRYSTAL STRUCTURE OF THE MYOSTATIN:FOLLISTATIN 288 COMPLEX
75, 3hh2B, 0.7370, 2.82, 0.317, 109, 101, CRYSTAL STRUCTURE OF THE MYOSTATIN:FOLLISTATIN 288 COMPLEX
76, 5vt2B, 0.7367, 2.16, 0.200, 108, 100, CRYSTAL STRUCTURE OF GROWTH DIFFERENTIATION FACTOR
77, 2gooD, 0.7363, 2.33, 0.343, 104, 99, TERNARY COMPLEX OF BMP-2 BOUND TO BMPR-IA-ECD AND ACTRII-ECD
78, 2b0uA, 0.7352, 2.78, 0.363, 116, 102, THE STRUCTURE OF THE FOLLISTATIN:ACTIVIN COMPLEX
79, 3b4vB, 0.7335, 2.35, 0.367, 114, 98, X-RAY STRUCTURE OF ACTIVIN IN COMPLEX WITH FSTL3
80, 5i05A, 0.7331, 2.34, 0.267, 107, 101, CRYSTAL STRUCTURE OF HUMAN BMP9 AT 1.87 A RESOLUTION
81, 1zkzA, 0.7329, 2.22, 0.270, 107, 100, CRYSTAL STRUCTURE OF BMP9
82, 2qjbB, 0.7323, 2.46, 0.343, 104, 99, CRYSTAL STRUCTURE ANALYSIS OF BMP-2 IN COMPLEX WITH BMPR-IA VARIANT IA/IB
83, 2r52B, 0.7320, 2.29, 0.343, 105, 99, CRYSTAL STRUCTURE ANALYSIS OF BONE MORPHOGENETIC PROTEIN-6 (BMP-6)
84, 2b0uB, 0.7319, 2.71, 0.360, 116, 100, THE STRUCTURE OF THE FOLLISTATIN:ACTIVIN COMPLEX
85, 2p6aB, 0.7318, 2.77, 0.350, 116, 103, THE STRUCTURE OF THE ACTIVIN:FOLLISTATIN 315 COMPLEX
86, 3bmpA, 0.7300, 2.53, 0.343, 106, 99, HUMAN BONE MORPHOGENETIC PROTEIN-2 (BMP-2)
87, 1es7A, 0.7296, 2.42, 0.343, 104, 99, COMPLEX BETWEEN BMP-2 AND TWO BMP RECEPTOR IA ECTODOMAINS
88, 2gooA, 0.7294, 2.33, 0.347, 103, 98, TERNARY COMPLEX OF BMP-2 BOUND TO BMPR-IA-ECD AND ACTRII-ECD
89, 2qjaB, 0.7291, 2.63, 0.343, 104, 99, CRYSTAL STRUCTURE ANALYSIS OF BMP-2 IN COMPLEX WITH BMPR-IA VARIANT B12
90, 1es7C, 0.7290, 2.43, 0.343, 104, 99, COMPLEX BETWEEN BMP-2 AND TWO BMP RECEPTOR IA ECTODOMAINS
91, 5vqfC, 0.7272, 2.41, 0.890, 340, 100, CRYSTAL STRUCTURE OF PRO-TGF-BETA 1
92, 3b4vF, 0.7272, 2.34, 0.381, 114, 97, X-RAY STRUCTURE OF ACTIVIN IN COMPLEX WITH FSTL3
93, 1rewA, 0.7268, 2.28, 0.347, 103, 98, STRUCTURAL REFINEMENT OF THE COMPLEX OF BONE MORPHOGENETIC PROTEIN 2 AND ITS TYPE IA RECEPTOR
94, 2qcwA, 0.7262, 2.23, 0.357, 104, 98, CRYSTAL STRUCTURE OF BONE MORPHOGENETIC PROTEIN-6 (BMP-6)
95, 5vt2A, 0.7253, 2.42, 0.158, 108, 101, CRYSTAL STRUCTURE OF GROWTH DIFFERENTIATION FACTOR
96, 3bk3B, 0.7250, 2.45, 0.327, 104, 98, CRYSTAL STRUCTURE OF THE COMPLEX OF BMP-2 AND THE FIRST VON WILLEBRAND DOMAIN TYPE C OF CROSSVEINLESS-2
97, 4ycgD, 0.7249, 2.49, 0.283, 106, 99, PRO-BONE MORPHOGENETIC PROTEIN 9
98, 2p6aA, 0.7248, 2.68, 0.356, 116, 101, THE STRUCTURE OF THE ACTIVIN:FOLLISTATIN 315 COMPLEX
99, 2qj9B, 0.7244, 2.52, 0.347, 103, 98, CRYSTAL STRUCTURE ANALYSIS OF BMP-2 IN COMPLEX WITH BMPR-IA VARIANT B1
100, 1rewB, 0.7244, 2.16, 0.351, 103, 97, STRUCTURAL REFINEMENT OF THE COMPLEX OF BONE MORPHOGENETIC PROTEIN 2 AND ITS TYPE IA RECEPTOR
101, 5vqfA, 0.7237, 2.40, 0.890, 335, 100, CRYSTAL STRUCTURE OF PRO-TGF-BETA 1
102, 2qjaA, 0.7215, 2.54, 0.337, 104, 98, CRYSTAL STRUCTURE ANALYSIS OF BMP-2 IN COMPLEX WITH BMPR-IA VARIANT B12
103, 2h62A, 0.7215, 2.57, 0.343, 104, 99, CRYSTAL STRUCTURE OF A TERNARY LIGAND-RECEPTOR COMPLEX OF BMP-2
104, 4yciD, 0.7214, 2.42, 0.286, 105, 98, NON-LATENT PRO-BONE MORPHOGENETIC PROTEIN 9
105, 4ycgC, 0.7214, 2.51, 0.283, 106, 99, PRO-BONE MORPHOGENETIC PROTEIN 9
106, 4yciC, 0.7212, 2.39, 0.286, 105, 98, NON-LATENT PRO-BONE MORPHOGENETIC PROTEIN 9
107, 2r53B, 0.7212, 2.52, 0.350, 107, 100, CRYSTAL STRUCTURE ANALYSIS OF BONE MORPHOGENETIC PROTEIN-6 VARIANT B2 (B2-BMP-6)
108, 5jhwA, 0.7204, 3.00, 0.324, 109, 102, CRYSTAL STRUCTURE OF THE GDF11:FOLLISTATIN 288 COMPLEX
109, 5e4gA, 0.7202, 2.94, 0.320, 108, 103, CRYSTAL STRUCTURE OF HUMAN GROWTH DIFFERENTIATION FACTOR 11 (GDF-11)
110, 3rjrC, 0.7196, 2.45, 0.890, 343, 100, CRYSTAL STRUCTURE OF PRO-TGF BETA 1
111, 3rjrA, 0.7193, 2.32, 0.899, 340, 99, CRYSTAL STRUCTURE OF PRO-TGF BETA 1
112, 1m4uL, 0.7193, 2.51, 0.330, 112, 97, CRYSTAL STRUCTURE OF BONE MORPHOGENETIC PROTEIN-7 (BMP-7) IN COMPLEX WITH THE SECRETED ANTAGONIST NOGGIN
113, 4midA, 0.7186, 2.61, 0.384, 105, 99, CRYSTAL STRUCTURE OF ACTIVIN A/BMP2 CHIMERA
114, 2qj9A, 0.7182, 2.60, 0.343, 104, 99, CRYSTAL STRUCTURE ANALYSIS OF BMP-2 IN COMPLEX WITH BMPR-IA VARIANT B1
115, 3bk3A, 0.7172, 2.54, 0.327, 104, 98, CRYSTAL STRUCTURE OF THE COMPLEX OF BMP-2 AND THE FIRST VON WILLEBRAND DOMAIN TYPE C OF CROSSVEINLESS-2
116, 3b4vA, 0.7167, 2.64, 0.357, 109, 98, X-RAY STRUCTURE OF ACTIVIN IN COMPLEX WITH FSTL3
117, 5vz3A, 0.7164, 2.79, 0.157, 108, 102, GROWTH FACTOR CRYSTAL STRUCTURE AT 1.97 ANGSTROM RESOLUTION
118, 2qjbA, 0.7158, 2.55, 0.347, 103, 98, CRYSTAL STRUCTURE ANALYSIS OF BMP-2 IN COMPLEX WITH BMPR-IA VARIANT IA/IB
119, 4mplA, 0.7157, 2.53, 0.270, 107, 100, CRYSTAL STRUCTURE OF BMP9 AT 1.90 ANGSTROM
120, 5jhwB, 0.7150, 3.01, 0.324, 109, 102, CRYSTAL STRUCTURE OF THE GDF11:FOLLISTATIN 288 COMPLEX
121, 3rjrB, 0.7141, 2.11, 0.907, 330, 97, CRYSTAL STRUCTURE OF PRO-TGF BETA 1
122, 5vz4A, 0.7137, 2.60, 0.167, 108, 102, RECEPTOR-GROWTH FACTOR CRYSTAL STRUCTURE AT 2.20 ANGSTROM RESOLUTION
123, 3b4vE, 0.7086, 2.66, 0.361, 107, 97, X-RAY STRUCTURE OF ACTIVIN IN COMPLEX WITH FSTL3
124, 3rjrD, 0.7035, 2.20, 0.907, 342, 97, CRYSTAL STRUCTURE OF PRO-TGF BETA 1
125, 5tx6C, 0.7011, 0.71, 0.802, 81, 81, STRUCTURE OF TGF-BETA2 DERIVATIVE WITH DELETION OF RESIDUES 52-71 AND 10 SINGLE AMINO ACID MUTATIONS (MMTGF-BETA2-7M)
126, 5hzwB, 0.7002, 2.65, 0.273, 105, 99, CRYSTAL STRUCTURE OF THE ORPHAN REGION OF HUMAN ENDOGLIN/CD105 IN COMPLEX WITH BMP9
127, 3sekB, 0.6931, 2.88, 0.313, 109, 99, CRYSTAL STRUCTURE OF THE MYOSTATIN:FOLLISTATIN-LIKE 3 COMPLEX
128, 5ffoC, 0.6906, 2.07, 0.957, 305, 93, INTEGRIN ALPHA V BETA 6 IN COMPLEX WITH PRO-TGF-BETA
129, 5vqfB, 0.6819, 2.34, 0.895, 320, 95, CRYSTAL STRUCTURE OF PRO-TGF-BETA 1
130, 2arvA, 0.6806, 2.81, 0.344, 116, 96, STRUCTURE OF HUMAN ACTIVIN A
131, 5vqfD, 0.6797, 2.39, 0.884, 335, 95, CRYSTAL STRUCTURE OF PRO-TGF-BETA 1
132, 1ktzA, 0.6776, 1.79, 0.780, 82, 82, CRYSTAL STRUCTURE OF THE HUMAN TGF-BETA TYPE II RECEPTOR EXTRACELLULAR DOMAIN IN COMPLEX WITH TGF-BETA3
133, 5ffoG, 0.6734, 1.80, 1.000, 297, 88, INTEGRIN ALPHA V BETA 6 IN COMPLEX WITH PRO-TGF-BETA
134, 2arvB, 0.6721, 3.00, 0.361, 106, 97, STRUCTURE OF HUMAN ACTIVIN A
135, 5f3hK, 0.6619, 2.38, 0.330, 105, 91, STRUCTURE OF MYOSTATIN IN COMPLEX WITH HUMANIZED RK35 ANTIBODY
136, 5f3hJ, 0.6536, 2.50, 0.319, 104, 91, STRUCTURE OF MYOSTATIN IN COMPLEX WITH HUMANIZED RK35 ANTIBODY
137, 5f3bC, 0.6512, 2.53, 0.333, 106, 90, STRUCTURE OF MYOSTATIN IN COMPLEX WITH CHIMERIC RK35 ANTIBODY
138, 5vqpA, 0.6476, 2.80, 0.830, 322, 94, CRYSTAL STRUCTURE OF HUMAN PRO-TGF-BETA1
139, 1s4yB, 0.6447, 3.30, 0.387, 111, 93, CRYSTAL STRUCTURE OF THE ACTIVIN/ACTRIIB EXTRACELLULAR DOMAIN
140, 5f3hI, 0.6444, 2.61, 0.319, 104, 91, STRUCTURE OF MYOSTATIN IN COMPLEX WITH HUMANIZED RK35 ANTIBODY
141, 5ntuA, 0.6374, 3.02, 0.312, 308, 93, CRYSTAL STRUCTURE OF HUMAN PRO-MYOSTATIN PRECURSOR AT 2.6 A RESOLUTION
142, 5uhmA, 0.6372, 2.12, 0.354, 87, 82, APO-STRUCTURE OF MATURE GROWTH DIFFERENTIATION FACTOR 11
143, 5uhmB, 0.6367, 2.04, 0.366, 87, 82, APO-STRUCTURE OF MATURE GROWTH DIFFERENTIATION FACTOR 11
144, 5f3hL, 0.6343, 2.75, 0.319, 104, 91, STRUCTURE OF MYOSTATIN IN COMPLEX WITH HUMANIZED RK35 ANTIBODY
145, 5f3bD, 0.6255, 2.44, 0.337, 103, 86, STRUCTURE OF MYOSTATIN IN COMPLEX WITH CHIMERIC RK35 ANTIBODY
146, 5ffoH, 0.6250, 2.32, 0.864, 325, 88, INTEGRIN ALPHA V BETA 6 IN COMPLEX WITH PRO-TGF-BETA
147, 2arpA, 0.6232, 2.86, 0.398, 105, 88, ACTIVIN A IN COMPLEX WITH FS12 FRAGMENT OF FOLLISTATIN
148, 1nysB, 0.6232, 1.94, 0.427, 85, 82, CRYSTAL STRUCTURE OF ACTIVIN A BOUND TO THE ECD OF ACTRIIB P41
149, 5ffoD, 0.6214, 2.67, 0.865, 322, 89, INTEGRIN ALPHA V BETA 6 IN COMPLEX WITH PRO-TGF-BETA
150, 1nyuB, 0.6206, 2.10, 0.410, 86, 83, CRYSTAL STRUCTURE OF ACTIVIN A BOUND TO THE ECD OF ACTRIIB
151, 5ji1B, 0.6103, 2.55, 0.349, 92, 83, CRYSTAL STRUCTURE OF GDF8
152, 5ji1A, 0.6088, 2.56, 0.329, 95, 85, CRYSTAL STRUCTURE OF GDF8
153, 5ntuB, 0.6037, 2.31, 0.358, 273, 81, CRYSTAL STRUCTURE OF HUMAN PRO-MYOSTATIN PRECURSOR AT 2.6 A RESOLUTION
154, 2askA, 0.5797, 2.54, 0.179, 101, 84, STRUCTURE OF HUMAN ARTEMIN
155, 1s4yD, 0.5774, 3.29, 0.391, 96, 87, CRYSTAL STRUCTURE OF THE ACTIVIN/ACTRIIB EXTRACELLULAR DOMAIN
156, 1agqD, 0.5753, 2.75, 0.138, 95, 87, GLIAL CELL-DERIVED NEUROTROPHIC FACTOR FROM RAT
157, 2gh0C, 0.5751, 2.61, 0.190, 100, 84, GROWTH FACTOR/RECEPTOR COMPLEX
158, 1nysD, 0.5713, 1.83, 0.444, 75, 72, CRYSTAL STRUCTURE OF ACTIVIN A BOUND TO THE ECD OF ACTRIIB P41
159, 5nxsA, 0.5702, 3.65, 0.375, 285, 88, CRYSTAL STRUCTURE OF HUMAN PRO-MYOSTATIN PRECURSOR AT 4.2 A RESOLUTION WITH EXPERIMENTAL PHASES FROM SEMET LABELLING
160, 1agqC, 0.5589, 2.76, 0.143, 91, 84, GLIAL CELL-DERIVED NEUROTROPHIC FACTOR FROM RAT
161, 5ty4B, 0.5579, 0.80, 0.892, 65, 65, MICROED STRUCTURE OF A COMPLEX BETWEEN MONOMERIC TGF-B AND ITS RECEPTOR TBRII AT 2.9 A RESOLUTION
162, 2v5eB, 0.5539, 3.43, 0.138, 101, 94, THE STRUCTURE OF THE GDNF:CORECEPTOR COMPLEX: INSIGHTS INTO RET SIGNALLING AND HEPARIN BINDING.
163, 2gh0D, 0.5532, 2.82, 0.193, 99, 83, GROWTH FACTOR/RECEPTOR COMPLEX
164, 1agqA, 0.5526, 3.07, 0.138, 91, 87, GLIAL CELL-DERIVED NEUROTROPHIC FACTOR FROM RAT
165, 3fubD, 0.5460, 3.33, 0.099, 103, 91, CRYSTAL STRUCTURE OF GDNF-GFRALPHA1 COMPLEX
166, 5mr5A, 0.5427, 3.22, 0.193, 98, 83, LIGAND-RECEPTOR COMPLEX.
167, 2gyrD, 0.5419, 2.85, 0.195, 97, 82, CRYSTAL STRUCTURE OF HUMAN ARTEMIN
168, 5mr9A, 0.5412, 3.26, 0.205, 99, 83, LIGAND-RECEPTOR COMPLEX.
169, 2gyzA, 0.5412, 2.87, 0.195, 97, 82, CRYSTAL STRUCTURE OF HUMAN ARTEMIN
170, 5mr5B, 0.5403, 3.28, 0.193, 98, 83, LIGAND-RECEPTOR COMPLEX.
171, 2gyrB, 0.5381, 2.80, 0.198, 97, 81, CRYSTAL STRUCTURE OF HUMAN ARTEMIN
172, 2gyrE, 0.5378, 2.72, 0.200, 97, 80, CRYSTAL STRUCTURE OF HUMAN ARTEMIN
173, 1m4uA, 0.5370, 2.54, 0.203, 199, 74, CRYSTAL STRUCTURE OF BONE MORPHOGENETIC PROTEIN-7 (BMP-7) IN COMPLEX WITH THE SECRETED ANTAGONIST NOGGIN
174, 3fubB, 0.5360, 3.15, 0.143, 92, 84, CRYSTAL STRUCTURE OF GDNF-GFRALPHA1 COMPLEX
175, 5mr9B, 0.5353, 3.28, 0.195, 101, 82, LIGAND-RECEPTOR COMPLEX.
176, 2gyrF, 0.5348, 3.00, 0.195, 97, 82, CRYSTAL STRUCTURE OF HUMAN ARTEMIN
177, 2gyrC, 0.5319, 2.76, 0.200, 97, 80, CRYSTAL STRUCTURE OF HUMAN ARTEMIN
178, 2gyrA, 0.5297, 2.83, 0.200, 97, 80, CRYSTAL STRUCTURE OF HUMAN ARTEMIN
179, 5nmzD, 0.5284, 3.37, 0.207, 99, 82, HUMAN NEURTURIN (97-197)
180, 5nxsB, 0.5279, 2.79, 0.400, 246, 75, CRYSTAL STRUCTURE OF HUMAN PRO-MYOSTATIN PRECURSOR AT 4.2 A RESOLUTION WITH EXPERIMENTAL PHASES FROM SEMET LABELLING
181, 5nmzB, 0.5257, 3.51, 0.205, 99, 83, HUMAN NEURTURIN (97-197)
182, 1agqB, 0.5254, 3.46, 0.154, 96, 91, GLIAL CELL-DERIVED NEUROTROPHIC FACTOR FROM RAT
183, 5mr4B, 0.5240, 3.39, 0.195, 98, 82, LIGAND-RECEPTOR COMPLEX.
184, 5hlzB, 0.5229, 3.33, 0.378, 86, 82, STRUCTURE OF PRO-ACTIVIN A COMPLEX AT 2.85 A RESOLUTION
185, 5mr4A, 0.5218, 3.33, 0.210, 98, 81, LIGAND-RECEPTOR COMPLEX.
186, 5hlzF, 0.5200, 3.37, 0.378, 86, 82, STRUCTURE OF PRO-ACTIVIN A COMPLEX AT 2.85 A RESOLUTION
187, 5nmzC, 0.5181, 3.22, 0.200, 101, 80, HUMAN NEURTURIN (97-197)
188, 5nmzA, 0.5166, 3.36, 0.198, 101, 81, HUMAN NEURTURIN (97-197)
189, 4ux8F, 0.5159, 3.09, 0.122, 93, 82, RET RECOGNITION OF GDNF-GFRALPHA1 LIGAND BY A COMPOSITE BINDING SITE PROMOTES MEMBRANE-PROXIMAL SELF-ASSOCIATION
190, 4ux8D, 0.5159, 3.09, 0.122, 93, 82, RET RECOGNITION OF GDNF-GFRALPHA1 LIGAND BY A COMPOSITE BINDING SITE PROMOTES MEMBRANE-PROXIMAL SELF-ASSOCIATION
191, 5hlzH, 0.5131, 3.33, 0.387, 84, 80, STRUCTURE OF PRO-ACTIVIN A COMPLEX AT 2.85 A RESOLUTION
192, 5hlyA, 0.5127, 3.50, 0.373, 291, 83, STRUCTURE OF PRO-ACTIVIN A PRECURSOR AT 2.3 A RESOLUTION
193, 2askB, 0.5108, 3.51, 0.101, 101, 89, STRUCTURE OF HUMAN ARTEMIN
194, 5hlzD, 0.5036, 3.33, 0.385, 82, 78, STRUCTURE OF PRO-ACTIVIN A COMPLEX AT 2.85 A RESOLUTION
195, 5hk5E, 0.5030, 3.12, 0.171, 128, 76, STRUCTURE OF THE GREM2-GDF5 INHIBITORY COMPLEX
196, 5hk5G, 0.5022, 3.11, 0.171, 129, 76, STRUCTURE OF THE GREM2-GDF5 INHIBITORY COMPLEX
197, 5hk5F, 0.5008, 3.11, 0.171, 129, 76, STRUCTURE OF THE GREM2-GDF5 INHIBITORY COMPLEX
